In the News / Politics

A New Approach with an Old Drug: Colchicine and Heart Disease

By: Mathew Fontanez, PharmD Candidate c/o 2022               What place does the familiar gout medication colchicine have in the fight…

5 years ago

Desmopressin Challenge for Von Willebrand’s Disease in the Setting of Myasthenia Gravis

By: Oluwafemi Popoola, PharmD Candidate c/o 2021, SUNY Binghamton School of Pharmacy & Pharmaceutical Sciences              A patient with past…

5 years ago

Pharmaceutical Breakthrough for the Treatment of Duchenne Muscular Dystrophy

By: Rubab Hassan, PharmD Candidate c/o 2022              Duchenne muscular dystrophy (DMD) is a genetic disorder that causes muscle degeneration…

5 years ago

Correlation of Salt-Intake and Hypertension

By: Jordan Plair, PharmD Candidate c/o 2022 and Marina Beshara, PharmD Candidate c/o 2022              While the focus over the…

5 years ago

Connecting the Dots: Ankylosing Spondylitis and Heart Disease

By: Jennifer Galvet, PharmD Candidate c/o 2024              Ankylosing spondylitis (AS) is a systemic inflammatory condition that primarily affects a…

5 years ago

FDA approves Vibegron (Gemtesa®) for the Treatment of Patients with Symptoms of Overactive Bladder

By: Arya Firoozan, PharmD Candidate c/o 2023              Overactive bladder (OAB) is a condition that causes a sudden and frequent…

5 years ago

Bamlanivimab for the treatment of COVID-19

By: Daniela Farzadfar, PharmD,PGY-1 Resident at Long Island Jewish Medical Center              In March 2020, the World Health Organization (WHO)…

5 years ago

Insulin Monitoring System for Pediatric patients

By: Lyana Sayilar, PharmD Candidate c/o 2022              On August 31, 2020, the FDA approved the first automated diabetes management…

5 years ago

Who is COVID-19 hitting the hardest?

By: Pooja Dasgupta and Sonya Wadhawan, PharmD Candidates c/o 2025              The coronavirus, also known as SARS CoV-2 or COVID-19,…

5 years ago

Fostemsavir: New drug for the treatment of HIV-1 resistant patients

By: Bisma Sekhery, PharmD Candidate c/o 2021              Fostemsavir (Rukobia) is a new Food and Drug Administration (FDA) approved antiretroviral…

5 years ago